David Andrew Tompkins (D Andrew Tompkins)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Alcohol Use Disorder

Ejection Fraction

Preterm Infants

Top Venues

Addiction (Abingdon, England)

Addiction biology

UCSF School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSF School of Medicine Sep 25 2017

United States

Director, Division of Substance Abuse and Addiction Medicine / Associate Clinical Professor :: Psychiatry

Johns Hopkins School of Medicine Jul 01 2010 - Sep 07 2017

United States

Assistant Professor :: Psychiatry and Behavioral Sciences

Publications

Meredith C Meacham, Alicia L Nobles, David Andrew Tompkins, Johannes Thrul
"I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PloS one 17 (2) (2022)
Kelly E Dunn, Elise M Weerts, Andrew S Huhn, Jennifer R Schroeder, David Andrew Tompkins, George E Bigelow, Eric C Strain
Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes. Addiction biology 25 (1) (2018)
Brantley P Jarvis, August F Holtyn, Shrinidhi Subramaniam, David Andrew Tompkins, Emmanuel A Oga, George E Bigelow, Kenneth Silverman
Extended-release injectable naltrexone for opioid use disorder: a systematic review. Addiction (Abingdon, England) 113 (7) (2018)
David Andrew Tompkins, Andrew S Huhn, Patrick S Johnson, Michael T Smith, Eric C Strain, Robert R Edwards, Matthew W Johnson
To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction (Abingdon, England) 113 (1) (2017)